Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: Implications for establishment of a Th1/Th2 bias

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 64-73

  Charles, Peter C ^a   Weber, Kirsten S ^a   Cipriani, Barbara ^a,b   Brosnan, Celia F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b IRCCS   (Italy)

Author keywords

Chemokine receptor; Chemokines; Cytokines; Th1 Th2; Virus

Indexed keywords

BETA INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CYTOKINE; GAMMA INTERFERON; LYMPHOTOXIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPLEEN; STRAIN DIFFERENCE; TH1 CELL; TH2 CELL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CHEMOKINES; CLONING, MOLECULAR; CYTOKINES; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TH1 CELLS; TH2 CELLS; TISSUE DISTRIBUTION;

EID: 0033386197     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00189-7     Document Type: Article

References (55)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787.
2. Alimzhanov M.B., Kuprash D.V., Kosco-Vilbois M.H., Luz A., Turetskaya R.L., Tarakhovsky A., Rajewsky K., Nedospasov S.A., Pfeffer K. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9302.
3. Autenrieth I.B., Beer M., Bohn E., Kaufmann S.H., Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:1994;2590.
4. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565.
5. Belardelli F., Gresser I. The neglected role of type I interferon in the T cell response: implications for its clinical use. Immunol. Today. 17:1996;369.
6. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P.A., Mantovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129.
7. + T lymphocytes [see comments]. Immunol. Today. 9:1988;268.
8. Bright J.J., Sriram S. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161:1998;1772.
9. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60.
10. Butterfield R.J., Sudweeks J.D., Blankenhorn E.P., Korngold R., Marini J.C., Todd J.A., Roper R.J., Teuscher C. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161:1998;1860.
11. Charles P.C., Guida J.D., Brosnan C.F., Horwitz M.S. Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology. 245:1998;216.
12. Charles P.C., Chen X., Horwitz M.S., Brosnan C.F. Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J. Neurovirol. 5:1999;55.
13. Daigneault L., Coulombe B., Skup D. Regulation of interferon gene expression: mechanism of action of the If-1 locus. J. Virol. 62:1988;1125.
14. D'Apuzzo M., Rolink A., Loetscher M., Hoxie J.A., Clark-Lewis I., Melchers F., Baggiolini M., Moser B. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27:1997;1788.
15. Dhib-Jalbut S. Mechanisms of interferon beta action in multiple sclerosis. Mult. Scler. 3:1997;397.
16. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50.
17. Galat A., Riviere S., Bouet F. Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett. 319:1993;233.
18. Gao J.L., Murphy P.M. Cloning and differential tissue-specific expression of three mouse beta chemokine receptor-like genes, including the gene for a functional macrophage inflammatory protein-1 alpha receptor. J. Biol. Chem. 270:1995;17494.
19. Gorham J.D., Guler M.L., Fenoglio D., Gubler U., Murphy K.M. Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. J. Immunol. 161:1998;1664.
20. Guida J.D., Brosnan C.F., Fejer G., Pirofski L., Horwitz M.S. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J. Virol. 69:1995;7674-7681.
21. + T cells from young and old mice. J. Immunol. 150:1993;3602.
22. + alpha beta-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5:1993;371.
23. + T cells through IL-12 produced by Listeria-induced macrophages [see comments]. Science. 260:1993;547.
24. Hsieh C.S., Macatonia S.E., O'Garra A., Murphy K.M. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:1995;713.
25. Karpus W.J., Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukocyte Biol. 62:1997;681.
26. Karpus W.J., Ransohoff R.M. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161:1998;2667.
27. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., Barrett T.A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158:1997;4129.
28. Karpus W.J., Kennedy K.J., Kunkel S.L., Lukacs N.W. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 187:1998;733.
29. Koni P.A., Sacca R., Lawton P., Browning J.L., Ruddle N.H., Flavell R.A. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity. 6:1997;491.
30. Kring S.C., King C.S., Spindler K.R. Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred swiss mice. J. Virol. 69:1995;8084.
31. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., Roberts A.B., Sporn M.B., Ward J.M., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90:1993;770.
32. Kunkel S.L. Th1- and Th2-type cytokines regulate chemokine expression. Biol. Signals. 5:1996;197.
33. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T lymphocytes [see comments]. J. Exp. Med. 184:1996;963.
34. Lukacs N.W., Chensue S.W., Karpus W.J., Lincoln P., Keefer C., Strieter R.M., Kunkel S.L. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am. J. Pathol. 150:1997;1861.
35. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436.
36. Matsubara S., Okumura S. Experimental autoimmune myositis in SJL/J mice produced by immunization with syngeneic myosin B fraction. Transfer by both immunoglobulin G and T cells. J. Neurol. Sci. 144:1996;171.
37. McCartney-Francis N.L., Wahl S.M. Transforming growth factor beta: a matter of life and death. J. Leukocyte Biol. 55:1994;401.
38. McRae B.L., Semnani R.T., Hayes M.P., van Seventer G.A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160:1998;4298.
39. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348.
40. Post T.W., Bozic C.R., Rothenberg M.E., Luster A.D., Gerard N., Gerard C. Molecular characterization of two murine eosinophil beta chemokine receptors. J. Immunol. 155:1995;5299.
41. Preston P.M. Macrophages and protective immunity in Mycobacterium lepraemurium infections in a 'resistant' (C57Bl) and a 'susceptible' (BALB/c) mouse strain. Clin. Exp. Immunol. 47:1982;243.
42. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825.
43. Rothenberg M.E., MacLean J.A., Pearlman E., Luster A.D., Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:1997;785.
44. Sad S., Mosmann T.R. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:1994;3514.
45. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:1998;875.
46. Segal R., Bermas B.L., Dayan M., Kalush F., Shearer G.M., Mozes E. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J. Immunol. 158:1997;3009.
47. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693.
48. Streilein J.W., Takeuchi M., Taylor A.W. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum. Immunol. 52:1997;138.
49. Suzuki Y., Yang Q., Remington J.S. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii. J. Parasitol. 81:1995;1032.
50. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817.
51. Taub D.D., Turcovski-Corrales S.M., Key M.L., Longo D.L., Murphy W.J. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:1996;2095.
52. Teuscher C., Butterfield R.J., Ma R.Z., Zachary J.F., Doerge R.W., Blankenhorn E.P. Sequence polymorphisms in the chemokines scya1 (TCA-3), scya2 (monocyte chemoattractant protein (MCP)-1), and scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J. Immunol. 163:1999;2262.
53. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335.
54. Wenner C.A., Guler M.L., Macatonia S.E., O'Garra A., Murphy K.M. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:1996;1442.
55. Zawatzky R., Wurmbaeck H., Falk W., Homfeld A. Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. J. Virol. 65:1991;4839.